BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30591319)

  • 1. Utility of copeptin for predicting long-term clinical outcomes in patients with heart failure.
    Yoshikawa Y; Shiomi H; Kuwahara K; Sowa N; Yaku H; Yamashita Y; Tazaki J; Imai M; Kato T; Saito N; Shizuta S; Ono K; Kimura T
    J Cardiol; 2019 May; 73(5):379-385. PubMed ID: 30591319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
    Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction.
    Pozsonyi Z; Förhécz Z; Gombos T; Karádi I; Jánoskuti L; Prohászka Z
    Heart Lung Circ; 2015 Apr; 24(4):359-67. PubMed ID: 25618448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
    Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
    Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copeptin in Heart Failure, Post-Left Ventricular Assist Device and Post-Heart Transplantation.
    Zabarovskaja S; Hage C; Gabrielsen A; Mellbin L; Lund LH
    Heart Lung Circ; 2017 Feb; 26(2):143-149. PubMed ID: 27523461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copeptin levels and invasive hemodynamics in patients with advanced heart failure.
    Balling L; Goetze JP; Jung MH; Rossing K; Boesgaard S; Gustafsson F
    Biomark Med; 2018 Aug; 12(8):861-870. PubMed ID: 30058349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copeptin as a biomarker in heart failure.
    Balling L; Gustafsson F
    Biomark Med; 2014; 8(6):841-54. PubMed ID: 25224940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.
    Tentzeris I; Jarai R; Farhan S; Perkmann T; Schwarz MA; Jakl G; Wojta J; Huber K
    Eur J Heart Fail; 2011 Jul; 13(7):726-33. PubMed ID: 21616953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study.
    Winther JA; Brynildsen J; Høiseth AD; Strand H; Følling I; Christensen G; Nygård S; Røsjø H; Omland T
    Respir Res; 2017 Nov; 18(1):184. PubMed ID: 29100503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
    Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
    J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
    Maisel A; Xue Y; Shah K; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand IS; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    Circ Heart Fail; 2011 Sep; 4(5):613-20. PubMed ID: 21765124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Regulation of Plasma Copeptin Levels in Patients with Heart Failure: A Single-Center Prospective Study.
    Iwashita N; Nara N; Sato R; Nakatogawa T; Kobayashi S; Zama S; Mita M; Hishinuma S; Shoji M
    Tohoku J Exp Med; 2016 Jul; 239(3):213-21. PubMed ID: 27396431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic performance of copeptin among patients with acute decompensated heart failure.
    Ozmen C; Deveci OS; Tepe O; Yesildas C; Ünal İ; Yıldız İ; Eker Akıllı R; Deniz A; Demir M; Kanadaşı M; Usal A
    Acta Cardiol; 2021 Oct; 76(8):842-851. PubMed ID: 32666903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copeptin in Heart Failure.
    Balling L; Gustafsson F
    Adv Clin Chem; 2016; 73():29-64. PubMed ID: 26975969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.
    Smaradottir MI; Ritsinger V; Gyberg V; Norhammar A; Näsman P; Mellbin LG
    Diab Vasc Dis Res; 2017 Mar; 14(2):69-76. PubMed ID: 28118730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copeptin is an independent prognostic factor for transplant-free survival in cirrhosis.
    Kerbert AJ; Weil D; Verspaget HW; Moréno JP; van Hoek B; Cervoni JP; Di Martino V; Coenraad MJ; Thevenot T
    Liver Int; 2016 Apr; 36(4):530-7. PubMed ID: 26502363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copeptin as a predictive marker of incident heart failure.
    Schill F; Timpka S; Nilsson PM; Melander O; Enhörning S
    ESC Heart Fail; 2021 Aug; 8(4):3180-3188. PubMed ID: 34056865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of copeptin and cancer antigen 125 in acute heart failure patients with atrial fibrillation and their correlations with short-term cardiovascular events].
    Ding Y; Wang Q; Yang Y; Wang L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Nov; 30(11):1024-1028. PubMed ID: 30541639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.